Molecular detection of circulating Sezary cells in patients with mycosis fungoides: could it predict future development of secondary Sezary syndrome? A single-institution experience

References

• Willemze R, Jaffe ES, Burg G, . WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–3765.
   PubMed Web of Science ®Google Scholar
• van Doorn R, Van Haselen CW, Voorst Vader PC, . Mycosis fungoides: disease evolution and prognosis of 209 Dutch patients. Arch Dermatol 2000;136:504–510.
   PubMed Web of Science ®Google Scholar
• Kim YH, Liu HL, Mraz-Gernhard S, . Long term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 2003;139:857–866.
   PubMed Web of Science ®Google Scholar
• Agar NS, Wedgeworth E, Crichton S, . Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 2010;28:4730–4739.
   PubMed Web of Science ®Google Scholar
• Massone C, Kodama K, Kerl H, . Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients. Am J Surg Pathol 2005;29:550–560.
   PubMed Web of Science ®Google Scholar
• Lutzner MA, Jordan HW. The ultrastructure of an abnormal cell in Sezary syndrome. Blood 1968;31:719–726.
   PubMed Web of Science ®Google Scholar
• Olsen E, Vonderheid E, Pimpinelli N, . Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007;110:1713–1722.
   PubMed Web of Science ®Google Scholar
• Scarisbrick JJ, Whittaker S, Evans AV, . Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 2001;97:624–630.
   PubMed Web of Science ®Google Scholar
• Vonderheid EC, Pena J, Nowell P. Sezary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging. Leuk Lymphoma 2006;47:1841–1856.
   PubMed Web of Science ®Google Scholar
• Duncan SC, Winkelmann RK. Circulating Sezary cells in hospitalized dermatology patients. Br J Dermatol 1978;99:171–178.
   PubMed Web of Science ®Google Scholar
• Kuchnio M, Sausville EA, Jaffe ES, . Flow cytometric detection of neoplastic T-cells in patients with mycosis fungoides bsed on levels of T-cell receptor expression. Am J Clin Pathol 1994;102:856–860.
   PubMed Web of Science ®Google Scholar
• Kelemen K, Guitart J, Kuzel T, . The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sezary syndrome. Am J Clin Pathol 2008;129:146–156.
   PubMed Web of Science ®Google Scholar
• Vonderheid EC, Bernengo MG. The Sezary syndrome: hematologic criteria. Hematol Oncol Clin North Am 2003;17:1367–1389.
   PubMed Web of Science ®Google Scholar
• Vonderheid EC, Bernengo MG, Burg G, . Update on erythrodermic cutaneous T-cell lymphoma: a report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002;46:95–106.
   PubMed Web of Science ®Google Scholar
• Muche JM, Sterry W, Gellrich S, . Peripheral blood T-cell clonality in mycosis fungoides and nonlymphoma controls. Diagn Mol Pathol 2003;12:142–150.
   PubMed Web of Science ®Google Scholar
• Frazier-Andrews EA, Woolford AJ, Russel-Jones R, . Detection of a peripheral blood T-cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 2000;114:117–121.
   PubMed Web of Science ®Google Scholar
• Muche JM, Lukowsky A, Asadullah K, . Demonstration of frequent occurrence of clonal T-cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood 1997;90:1636–1642.
   PubMed Web of Science ®Google Scholar
• Beylot-Barry M, Sibaud V, Thiebaut R, . Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas. J Invest Dermatol 2001;117:920–926.
   PubMed Web of Science ®Google Scholar
• Fraser-Andrews EA, Woolford AJ, Russell-Jones R, . Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 2000;114:117–121.
   PubMed Web of Science ®Google Scholar
• Bradford PT, Devesa SS, Anderson WF, . Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009;113:5064–5073.
   PubMed Web of Science ®Google Scholar
• Bunn PA, Lamberg SI. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 1979;63:725–728.
   PubMedGoogle Scholar
• Feng B, Jorgensen JL, Jones D, . Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging. Mod Pathol 2010;23:284–295.
   PubMed Web of Science ®Google Scholar
• Harmon CB, Witzig TE, Katzman JA, . Detection of circulating T cells with CD4 + CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. J Am Acad Dermatol 1996;35:404–410.
   PubMed Web of Science ®Google Scholar
• Bernengo MG, Novelli M, Quaglino P, . The relevance of the CD4 + CD26- subset in the identification of circulating Sezary cells. Br J Dermatol 2001;144:125–135.
   PubMed Web of Science ®Google Scholar
• van der Velden VH, van der Sluijs-Geling A, Gibson BE, . Clinical significance of flow cytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol. Leukemia 2010;24:1599–1606.
   PubMed Web of Science ®Google Scholar
• Muzzafar T, Medeiros LJ, Wang SA, . Aberrant underexpres sion of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry. Am J Clin Pathol 2009;132:692–698.
   PubMed Web of Science ®Google Scholar
• Campana D. Minimal residual disease in acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2010:7–12.
   PubMedGoogle Scholar
• Goeldel AL, Cornillet-Lefebvre P, Durlach A, . T-cell receptor gamma gene rearrangement in cutaneous T-cell lymphoma: comparative study of polymerase chain reaction with denaturing gradient gel electrophoresis and GeneScan analysis. Br J Dermatol 2010;162:822–829.
   PubMed Web of Science ®Google Scholar
• Delfau-Larue MH, Laroche L, Wechsler J, . Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood 2000;96:2987–2992.
   PubMed Web of Science ®Google Scholar
• Posnett DN, Sinha R, Kabak S, . Clonal populations of T-cells in normal elderly humans: the T-cell equivalent to “benign monoclonal gammopathy.” J Exp Med 1994;179:609–618.
   PubMed Web of Science ®Google Scholar
• Prince HM, Whittaker S, Hoppe RT. How I treat mycosis fungoides and Sézary syndrome. Blood 2009;114:4337–4353.
   PubMed Web of Science ®Google Scholar